bimekizumab shows favorable efficacy compared with other dmards for psa with philip j mease, md
Published 4 months ago • 128 plays • Length 10:09Download video MP4
Download video MP3
Similar videos
-
0:46
bimekizumab's efficacy in treating psoriatic #arthritis
-
6:28
philip mease, md: upadacitinib showing promise treating psoriatic arthritis
-
29:50
discussing psa: bimekizumab therapy in psa
-
1:37
get the skinny on bimekizumab in psa
-
1:37
philip mease, md: jak inhibitors for psoriatic arthritis
-
35:13
il-17 inhibitors in nonradiographic axial spondyloarthritis
-
1:04:14
diagnosis and management of psoriatic arthritis
-
38:14
discussing psa: long-term safety of ixekizumab & bimekizumab treatment in a tnfi-ir population
-
1:52
philip mease, md: treatments for psoriatic arthritis
-
21:22
bimekizumab in treating bdmard-naïve psa & upadacitinib in treating csdmard and bdmard ir psa
-
0:53
philip mease, md: guselkumab effective for psoriatic arthritis
-
6:27
the be complete and be optimal trials of bimekizumab in psa | joseph merola
-
3:21
efficacy and safety of bimekizumab in psoriatic arthritis patients
-
3:19
be complete and be optimal: how might bimekizumab impact psa clinical practice? | philippe carron
-
4:53
bimekizumab 52-week efficacy and safety in biologic dmard-naïve patients with active psa
-
29:30
axial psoriatic arthritis - philip mease, md
-
5:53
bimekizumab treatment in patients with psoriatic arthritis and tnfi-ir: results up to 1 year
-
2:31
dr. philip mease on late breaking: risankizumab in psoriatric arthritis
-
6:18
researcher comment: select-psa-2 | philip mease
-
3:37
breakthroughs in psoriasis and psoriatic arthritis therapies: bimekizumab, upadacitinib
-
24:08
rheumatology author prof philip mease: upadacitinib in psa